New dry eye treatment put to the test against current standard

NCT ID NCT05865457

Recruiting now Symptom relief Sponsor: TRB Chemedica International SA Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 24 times

Summary

This study tests whether a new treatment, BUFY02, works as well as an existing one, TRB02, for people with dry eye disease. About 80 participants will use the assigned eye drops daily for three months. Researchers will check eye health and ask about symptoms to see if both treatments are similarly effective and safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHRU Brest
RECRUITING

Brest, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
CHU Nice
RECRUITING

Nice, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpital Bicêtre
RECRUITING

Le Kremlin-Bicêtre, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Medical University Graz
RECRUITING

Graz, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••
VIROS
RECRUITING

Vienna, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DRY EYE DISEASE